申请人:IRONWOOD PHARMACEUTICALS, INC.
公开号:US20160311826A1
公开(公告)日:2016-10-27
The present patent application discloses at least the compounds according to Formula I shown below, or pharmaceutically acceptable salts thereof,
wherein ring J
B
, n, J
D
, J, o, X, X
1
, J, R
C
, and W are as defined herein. These compounds are useful as stimulators of soluble sGC.